openPR Logo
Press release

Gene Therapy Pipeline Insights, 2023: Clinical Trials, Latest Approvals, Therapies, Key Companies | Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech

06-13-2024 03:02 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Gene Therapy Pipeline Insights

Gene Therapy Pipeline Insights

"Gene Therapy Pipeline Insight, 2023" report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects across the Gene Therapy Market.
DelveInsight's, "Gene therapy Competitive landscape, 2023 [https://www.delveinsight.com/report-store/gene-therapy-competitive-landscape?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]," report provides comprehensive insights about 250+ companies and 300+ drugs in Gene therapy Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

The Gene Therapy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details.

Recent Developments in Gene Therapy Market [https://www.delveinsight.com/report-store/gene-therapy-competitive-landscape?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]:

*
June 2022: Transgene and BioInvent International Collaboration with MSD In June 2022, Transgene and BioInvent International announced a clinical trial collaboration and supply agreement with MSD, the tradename of Merck & Co. This partnership aims to evaluate the gene therapy BT-001 in combination with MSD's anti-PD-1 therapy KEYTRUDA (pembrolizumab) in a Phase I/IIa clinical trial for treating patients with solid tumors.

*
April 2022: ImmVira Partnership with Roche In April 2022, ImmVira announced a cooperation agreement with Roche to establish a clinical research partnership. This collaboration will conduct clinical studies in the U.S. on the combination therapy of ImmVira's MVR-T3011 IT and Roche's MEK inhibitor cobimetinib to evaluate the safety and efficacy of this combination strategy.

*
March 2022: Targovax and Agenus Collaboration In March 2022, Targovax announced a collaboration with Agenus to use their proprietary vaccine adjuvant QS-21 STIMULON as an immune-stimulatory component of the TG vaccines for future development and commercialization.

*
February 2022: Calidi Biotherapeutics and Edoc Acquisition Corp. Merger In February 2022, Calidi Biotherapeutics, Inc. and Edoc Acquisition Corp. announced a definitive merger agreement. Upon closing the transaction, expected in the second quarter of 2022, the combined company will be named Calidi Biotherapeutics, Inc. and led by Allan Camaisa, CEO and Chairman of the Board. Additionally, the combined company's common stock intends to list on the Nasdaq Capital Market.

*
January 2022: Transgene and PersonGen BioTherapeutics Collaboration In January 2022, Transgene and PersonGen BioTherapeutics announced a strategic collaboration to evaluate the feasibility and efficacy of combining PersonGen's TAA06 CAR-T cell injection with intravenous (IV) administration of an armed gene therapy from Transgene's Invir.IO Trademark platform in solid tumors, including pancreatic cancer and brain glioma. The collaboration aims to demonstrate the synergistic mechanisms to enhance CAR-T cell therapy. Under the agreement, Transgene will develop multiple new oncolytic virus (OV) candidates using its patented gene therapy backbone VVcopTK-RR- and Invir.IO Trademark technology platform for IV administration in combination with PersonGen's TAA06 CAR-T injection. PersonGen will evaluate the combination's efficacy in eliminating solid tumors in preclinical models.

Request for a detailed sample report @ https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape [https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Gene Therapy Overview

Gene therapy is a technique that uses genes to treat, prevent, or cure diseases and medical disorders. This approach often involves adding new copies of a gene to replace or supplement a defective or missing gene in a patient's cells. Gene therapy has been used to treat both inherited genetic diseases (e.g., hemophilia and sickle cell disease) and acquired disorders (e.g., leukemia).

Gene Therapy Mechanism of Action

Gene therapy works by introducing genetic material-DNA or RNA-into cells to alter the production of proteins. This alteration can correct imbalances caused by the overproduction, underproduction, or incorrect production of essential proteins within cells. The therapeutic genetic material, such as a functional gene, is delivered into the cell using a vector.

Vectors in Gene Therapy

A vector acts as a delivery system to transport the new genetic material into cells. Viruses are often used as vectors because they are naturally adept at entering cells. Scientists modify these viruses by removing their harmful genes, enabling them to safely deliver the therapeutic genetic material. This modified viral vector then inserts the new genetic material into the target cells. Before being used in humans, all viral vectors undergo extensive safety testing.

Gene Therapy Applications

Gene therapy has shown promise in treating a variety of conditions, including:

- Inherited Genetic Diseases: Such as hemophilia and sickle cell disease, where the therapy can replace or repair faulty genes.

- Acquired Disorders: Such as leukemia, where gene therapy can modify immune cells to better fight cancer.

Gene Therapy Safety and Development

The development of gene therapy involves rigorous testing to ensure safety and efficacy. This includes multiple stages of preclinical and clinical trials to evaluate the therapeutic potential and identify any risks. The continuous advancements in gene therapy research hold significant potential for providing long-lasting treatments and even cures for many genetic and acquired diseases.

Gene therapy represents a cutting-edge approach to medicine, offering hope for conditions that were once considered untreatable. As research progresses, the potential for gene therapy to transform medical treatment continues to expand.

Gene Therapy Pipeline Analysis

The report provides insights into:

The report provides detailed insights into emerging therapies in the Gene Therapy Market and the aggregate therapies developed by major pharma companies.

*
It accesses the different Gene Therapy therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development.

*
It outlines the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.

*
The report evaluates the drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.

*
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Gene Therapy Market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Analysis of Emerging Gene Therapy by Phases

The report covers the emerging products under different phases of clinical development like -

*
Late-stage products (Phase III)

*
Mid-stage products (Phase II)

*
Early-stage product (Phase I)

*
Pre-clinical and Discovery stage candidates

*
Discontinued & Inactive candidates

Key Companies in the Gene Therapy Market [https://www.delveinsight.com/report-store/gene-therapy-competitive-landscape?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] Include:Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech, Replimune, Istari Oncology, Immvira Pharma, Lokon Pharma, ORCA Therapeutics, Beijing SyngenTech, Tasly Pharmaceuticals, Turnstone Biologics, BioInvent Transgene, Elicera Therapeutics, Orgenesis, Virttu Biologics, Imugene, Astellas Pharma, Mustang Bio, Virogin Biotech, Memgen, Replimune, Immvira Pharma, PsiOxus Therapeutics, VCN Biosciences, Sorrento Therapeutics, Calidi Biotherapeutics, Replimune, TILT Biotherapeutics, DNAtrix, and many others.

Gene therapy drugs: ABECMA , ADSTILADRIN, ALLOCOR, BREYANZI, CARVYKTI, CLEVECORD, Ducord, HPC Cord Blood, GINTUIT

Request the Sample PDF to Get a Better Understanding of the Emerging Drugs and Key Companies @ https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape [https://www.delveinsight.com/sample-request/gene-therapy-competitive-landscape?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Table of Contents

1. Report Introduction

2. Executive Summary

3. Gene Therapy Current Treatment Patterns

4. Gene Therapy - DelveInsight's Analytical Perspective

5. Therapeutic Assessment

6. Gene Therapy Late Stage Products (Phase-III)

7. Gene Therapy Mid-Stage Products (Phase-II)

8. Gene Therapy Early Stage Products (Phase-I)

9. Pre-clinical Products and Discovery Stage Products

10. Inactive Products

11. Dormant Products

12. Gene Therapy Discontinued Products

13. Gene Therapy Product Profiles

14. Key Companies in the Gene Therapy Market

15. Key Products in the Gene Therapy Therapeutics Segment

16. Dormant and Discontinued Products

17. Gene Therapy Unmet Needs

18. Gene Therapy Future Perspectives

19. Gene Therapy Analyst Review

20. Appendix

21. Report Methodology

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=gene-therapy-pipeline-insights-2023-clinical-trials-latest-approvals-therapies-key-companies-candel-therapeutics-sillajen-biotherapeutics-wuhan-binhui-biotechnology-virogin-biotech]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gene Therapy Pipeline Insights, 2023: Clinical Trials, Latest Approvals, Therapies, Key Companies | Candel Therapeutics, SillaJen Biotherapeutics, Wuhan Binhui Biotechnology, Virogin Biotech here

News-ID: 3538158 • Views:

More Releases from ABNewswire

Major Maids House Cleaners: Exceptional St Pete House Cleaners Now Available In St. Petersburg, FL
Major Maids House Cleaners: Exceptional St Pete House Cleaners Now Available In …
Major Maids House Cleaners in St. Petersburg, FL, provides outstanding cleaning services. They shine in the industry with a stellar reputation, meticulous attention to detail, and a commitment to eco-friendly practices. Major Maids House Cleaners [https://www.majormaidshomecleaning.com/florida/st-petersburg] in St. Petersburg, FL, delivers exceptional services. They stand out in the industry with a stellar reputation, meticulous attention to detail, and an eco-conscious approach. Services range from regular to deep cleaning, addressing various needs
Experience Top-Notch Home Cleaning with Bright Side Services Inc.'s Maid Services
Experience Top-Notch Home Cleaning with Bright Side Services Inc.'s Maid Service …
Bright Side Services Inc.'s maid services encompass a comprehensive range of cleaning tasks, ensuring every aspect of your home receives thorough attention. From dusting and vacuuming to polishing surfaces and sanitising bathrooms, their professional cleaners are trained to deliver impeccable results. Whether you require a one-time deep clean or regular maintenance, their services can be tailored to meet your specific needs. In the realm of home maintenance, the demand for meticulous
Experience the Difference: Bright Side Services Inc. Launches Residential Cleaning Solutions
Experience the Difference: Bright Side Services Inc. Launches Residential Cleani …
In the ever-evolving world of home maintenance, the importance of a pristine living environment cannot be overstated. Recognising this necessity, Bright Side Services Inc. has introduced their exceptional residential cleaning services [https://brightsideservicesinc.com/#:~:text=busy%20schedule.%20Our-,residential%20cleaning%20services,-include%3A]. These offerings are designed to meet the needs of modern homeowners, providing comprehensive solutions that ensure every corner of your home gleams with cleanliness. Bright Side Services Inc. has built a reputation for excellence, and the launch of their
FunPartyCos Introduces a Diverse Range of Spiderman Costumes for Fans of All Ages
FunPartyCos Introduces a Diverse Range of Spiderman Costumes for Fans of All Age …
The world of cosplay has always been a vibrant space where fans can immerse themselves in the roles of their favorite characters. FunPartyCos, a leading provider of cosplay costumes, has unveiled an exciting lineup of Spiderman costumes designed to cater to fans of all ages and genders. Speaking on behalf of FunPartyCos, Sarah Johnson, the Cosplay Specialist, emphasized the inclusivity of their Spiderman costume collection. "Our goal at FunPartyCos is to

All 5 Releases


More Releases for Gene

Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Editing Market : A Market Study On Gene Editing And Cancer Therapy Techniqu …
Global Gene Editing Market Precision Business Insights (PBI) in its report titled “Global Gene Editing Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Gene editing or Genome editing is
Direct-to-consumer Genetic Testing Market: Top Players - Gene By Gene, MyHeritag …
Latest industry research report on: Global and United States Direct-to-consumer Genetic Testing Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the Direct-to-consumer Genetic Testing market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Direct-to-consumer Genetic Testing market by product